| Literature DB >> 24319401 |
Mohammed Khaled Bin Break1, M Ibrahim M Tahir, Karen A Crouse, Teng-Jin Khoo.
Abstract
Two bidentate Schiff base ligands having nitrogen sulphur donor sequence were derived from the condensation of S-benzyldithiocarbazate (SBDTC) with 2-chloroacetophenone and 4-chloroacetophenone to give S-benzyl- β -N-(2-chlorophenyl)methylenedithiocarbazate (NS2) and S-benzyl- β -N-(4-chlorophenyl)methylenedithiocarbazate (NS4) isomers. Each of the ligands was then chelated with Cd(2+), Zn(2+), Cu(2+), and Ni(2+). The compounds were characterized via IR spectroscopy and melting point while the structure of NS4 was revealed via X-ray crystallography. Finally, the compounds were screened for antimicrobial activity to investigate the effect that is brought by the introduction of the chlorine atom to the benzene ring. X-ray crystallographic analysis showed that the structure of NS4 is planar with a phenyl ring that is nearly perpendicular to the rest of the molecules. The qualitative antimicrobial assay results showed that NS4 and its complexes lacked antifungal activity while Gram-positive bacteria were generally inhibited more strongly than Gram-negative bacteria. Furthermore, NS4 metal complexes were inhibited more strongly than the ligand while the opposite was seen with NS2 ligand and its complexes due to the partial solubility in dimethyl sulfoxide (DMSO). It was concluded that generally NS2 derivatives have higher bioactivity than that of NS4 derivatives and that the Cd complexes of both ligands have pronounced activity specifically on K. rhizophila.Entities:
Year: 2013 PMID: 24319401 PMCID: PMC3844202 DOI: 10.1155/2013/362513
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1Schematic diagram of the synthesis procedure for NS4 and NS2 ligands.
Figure 1Proposed structure of the complexes.
Crystallographic data and structure refinement details of NS4.
| Empirical formula | C16H15ClN2S2 |
| Formula weight | 334.89 |
| Temperature (K) | 150 |
| Crystal class | Triclinic |
| Space group |
|
| Unit cell dimensions | |
|
| 6.2206(7) |
|
| 9.7222(10) |
|
| 13.5943(14) |
|
| 89.729(8) |
|
| 101.960(9) |
|
| 97.447(9) |
| Volume (Å3) | 797.32(15) |
|
| 2 |
|
| 1.39 |
| Radiation type | Cu K |
| Wavelength (Å) | 1.5418 |
| Crystal size (mm) | 0.06 × 0.08 × 0.18 |
|
| 3–72 |
| Reflections measured/independent | 7883/2834 ( |
|
| 71.6937 |
| Limiting indices | −7 ≤ |
| −11 ≤ | |
| −16 ≤ | |
| Refinement on |
|
|
| 0.066 |
|
| 0.178 |
| Goodness of fit (S) | 0.97 |
| Minimum and maximum residual electron density (eÅ−3) | −0.45 and 0.80 |
| Reflections used | 2821 |
| Number of parameters | 190 |
Physical properties and yield of the Schiff bases and their complexes.
| Compound | Colour | Yield | Melting point (°C) |
|---|---|---|---|
| SBDTC | White | 7.67 g | 124 |
| NS4 | Light yellow | 1.46 g | 138.5 |
| NS2 | White | 0.61 g | 178 |
| Zn(NS4)2 | Yellowish green | 0.65 g | 200 |
| Cd(NS4)2 | Yellowish brown | 2.81 g | 189 |
| Ni(NS4)2 | Dark green | 0.52 g | Decomposes at 309.5 |
| Cu(NS4)2 | Dark brown | 0.52 g | 190 |
| Zn(NS2)2 | White | 0.35 g | 159 |
| Cd(NS2)2 | Greyish green | 0.59 g | Decomposes at 170 |
| Ni(NS2)2 | Light green | 0.12 g | Decomposes at 160 |
| Cu(NS2)2 | Dark brown | 0.10 g | Decomposes at 205 |
IR spectral data of SBDTC, free ligand, and their complexes.
| Compound | Infrared absorption bands (frequency, cm−1) | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| SBDTC | 3451 | 3250, 3172 | 950 | 1048 | — | — | — | 2 peaks at 710, 698 |
|
| ||||||||
| NS4 | 3436 | — | 950 | 1051 | 1638 | — | — | (i) Aromatic C–H at 3166 |
|
| ||||||||
| NS2 | 3447 | — | 972 | 1023 | 1590 | — | — | (i) Aromatic C–H at 3285 |
|
| ||||||||
| Zn(NS4)2 | — | — | — | 1000 | 1400 | Obscured by other peaks | 3432 | Broad peak ~(500–900) |
|
| ||||||||
| Cd(NS4)2 | — | — | — | 1086 | 1450 | 600 | 3430 | (i) Peak at 822 |
|
| ||||||||
| Zn(NS2)2 | — | — | — | 1121 | 1578 | 750 | 3436 | (i) Peak at 697 |
|
| ||||||||
| Cd(NS2)2 | — | — | — | 1120 | 1421 | Obscured by other peaks | 3448 | (i) Peak at 700 |
|
| ||||||||
| Ni(NS4)2 | — | — | — | 1116 | 1400 | 500 | 3400 | (i) Peak at 827 |
|
| ||||||||
| Cu(NS4)2 | — | — | — | 1117 | 1406 | 619 | 3420 | (i) Peak at 825 |
|
| ||||||||
| Cu(NS2)2 | — | — | — | 1120 | 1406 | Obscured by other peaks | 3410 | Peak at 619 |
|
| ||||||||
| Ni(NS2)2 | — | — | — | 1110 | 1421 | 510 | 3430 | Peak at 620 |
(M–N)*: this refers to the dative bond that is formed between the metal ion (M) and the nitrogen (N) atom.
Figure 2Thione-thiol tautomerism.
Figure 3Deprotonation of the thiol by KOH.
Figure 4ORTEP plot of NS4 showing 50% probability displacement ellipsoids in addition to the atomic numbering scheme.
Summary of selected bond lengths found in NS4.
| Bond lengths (Å) | |||
|---|---|---|---|
| Cl1–C2 | 1.746(4) | C6–N7 | 1.285(5) |
| C2–C21 | 1.381(6) | N7–N8 | 1.370(4) |
| C3–H31 | 0.938 | N8–H81 | 0.870 |
| C5–C20 | 1.387(6) | C9–S18 | 1.660(4) |
| C9–S10 | 1.765(4) | N8–C9 | 1.343(5) |
| S10–C11 | 1.825(4) | ||
Summary of the bond angles in NS4.
| Bond angles (°) | |||
|---|---|---|---|
| Cl1–C2–C3 | 119.0(3)° | C6–N7–N8 | 119.1(3)° |
| N7–C6–C19 | 124.1(3)° | N7–N8–H81 | 120.673° |
| N7–N8–C9 | 118.7(3)° | N8–C9–S10 | 112.9(3)° |
| N8–C9–S18 | 122.3(3)° | S10–C9–S18 | 124.8(2)° |
| C9–S10–C11 | 102.76(17)° | S10–C11–C12 | 115.4(3)° |
Hydrogen bond geometry (Å, °).
| D–H⋯A | D–H | H⋯A | D⋯A | D–H⋯A |
|---|---|---|---|---|
| C14–H141⋯Cl1i | 0.94 | 2.88 | 3.813(5) | 173 |
| N8–H81⋯S18ii | 0.87 | 2.67 | 3.526(3) | 166 |
| C19–H191⋯S18ii | 0.98 | 2.80 | 3.440(4) | 124 |
| C11–H112⋯S18 (intramolecular) | 0.98 | 2.65 | 3.145(4) | 112 |
| C4–H41⋯N7 (intramolecular) | 0.94 | 2.41 | 2.742(5) | 100 |
Symmetry codes: i x + 1, y, z − 1; ii−x + 1, −y, −z.
Figure 5(a) Packing of molecules per unit cell viewed along the b-axis. (b) Packing diagram of NS4 showing the H81–S18 and H191–S18 hydrogen bond interactions. (c) Packing diagram of NS4 showing the Cl1–H141 hydrogen bond interactions. (d) Intramolecular hydrogen bond interactions within NS4 molecules.
Ratio of mean inhibition zone diameter of synthesized compounds to that of reference compounds.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| NS2 | |||||||
| Streptomycin | 1.25 | 1.38 | 1.56 | 1.08 | 1.03 | Not available | |
| Neomycin | 0.97 | 1.17 | 1.02 | 0.94 | 0.63 | 1.04 | |
| Chloramphenicol | 0.68 | 1.00 | 0.73 | Control has no effect | 0.92 | 0.99 | |
| SBDTC | 0.92 | 0.95 | 1.43 | 0.99 | 0.93 | 0.92 | 0.00 |
| Amphotericin B | 0.00 | ||||||
| Zn(NS2)2 | |||||||
| Streptomycin | 1.15 | 1.16 | 1.50 | 0.60 | 1.00 | Not available | |
| Neomycin | 0.89 | 0.98 | 0.99 | 0.52 | 0.62 | 0.90 | |
| Chloramphenicol | 0.63 | 0.84 | 0.71 | Control has no effect | 0.91 | 0.86 | |
| SBDTC | 0.85 | 0.80 | 1.38 | 0.55 | 0.91 | 0.80 | 1.25 |
| Amphotericin B | 1.21 | ||||||
| Cd(NS2)2 | |||||||
| Streptomycin | 0.63 | 0.52 | 2.11 | 0.51 | 1.13 | Not available | |
| Neomycin | 0.49 | 0.44 | 1.39 | 0.45 | 0.70 | 0.44 | |
| Chloramphenicol | 0.34 | 0.38 | 1.00 | Control has no effect | 1.02 | 0.42 | |
| SBDTC | 0.47 | 0.36 | 1.93 | 0.47 | 1.02 | 0.39 | 1.61 |
| Amphotericin B | 1.56 | ||||||
| Ni(NS2)2 | |||||||
| Streptomycin | 0.53 | 0.54 | 1.11 | 0.00 | 0.66 | Not available | |
| Neomycin | 0.41 | 0.46 | 0.73 | 0.00 | 0.41 | 0.00 | |
| Chloramphenicol | 0.29 | 0.39 | 0.52 | Control has no effect | 0.59 | 0.00 | |
| SBDTC | 0.39 | 0.37 | 1.02 | 0.00 | 0.60 | 0.00 | 0.92 |
| Amphotericin B | 0.90 | ||||||
| Cu(NS2)2 | |||||||
| Streptomycin | 0.50 | 0.00 | 0.00 | 0.00 | 0.55 | Not available | |
| Neomycin | 0.39 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | |
| Chloramphenicol | 0.27 | 0.00 | 0.00 | Control has no effect | 0.50 | 0.00 | |
| SBDTC | 0.37 | 0.00 | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 |
| Amphotericin B | 0.00 | ||||||
| NS4 | |||||||
| Streptomycin | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 | Not available | |
| Neomycin | 0.00 | 0.35 | 0.00 | 0.00 | 0.00 | 0.61 | |
| Chloramphenicol | 0.00 | 0.30 | 0.00 | Control has no effect | 0.00 | 0.58 | |
| SBDTC | 0.00 | 0.29 | 0.00 | 0.00 | 0.00 | 0.54 | 0.00 |
| Amphotericin B | 0.00 | ||||||
| Zn(NS4)2 | |||||||
| Streptomycin | 0.65 | 0.52 | 0.61 | 0.00 | 0.00 | Not available | |
| Neomycin | 0.51 | 0.44 | 0.40 | 0.00 | 0.00 | 0.51 | |
| Chloramphenicol | 0.36 | 0.38 | 0.29 | Control has no effect | 0.00 | 0.49 | |
| SBDTC | 0.48 | 0.36 | 0.56 | 0.00 | 0.00 | 0.46 | 0.00 |
| Amphotericin B | 0.00 | ||||||
| Cd(NS4)2 | |||||||
| Streptomycin | 0.55 | 0.42 | 2.46 | 0.00 | 0.00 | Not available | |
| Neomycin | 0.43 | 0.36 | 1.62 | 0.00 | 0.00 | 0.36 | |
| Chloramphenicol | 0.30 | 0.30 | 1.16 | Control has no effect | 0.00 | 0.34 | |
| SBDTC | 0.41 | 0.29 | 2.25 | 0.00 | 0.00 | 0.32 | 0.00 |
| Amphotericin B | 0.00 | ||||||
| Ni(NS4)2 | |||||||
| Streptomycin | 0.77 | 0.65 | 0.75 | 0.00 | 0.00 | Not available | |
| Neomycin | 0.60 | 0.55 | 0.49 | 0.00 | 0.00 | 0.69 | |
| Chloramphenicol | 0.42 | 0.47 | 0.35 | Control has no effect | 0.00 | 0.66 | |
| SBDTC | 0.57 | 0.45 | 0.68 | 0.00 | 0.00 | 0.61 | 0.00 |
| Amphotericin B | 0.00 | ||||||
| Cu(NS4)2 | |||||||
| Streptomycin | 0.73 | 0.42 | 0.67 | 0.00 | 0.00 | Not available | |
| Neomycin | 0.57 | 0.36 | 0.44 | 0.00 | 0.00 | 0.53 | |
| Chloramphenicol | 0.40 | 0.31 | 0.32 | Control has no effect | 0.00 | 0.50 | |
| SBDTC | 0.54 | 0.29 | 0.62 | 0.00 | 0.00 | 0.47 | 0.00 |
| Amphotericin B | 0.00 |
Figure 6
Figure 7
Figure 8Shows the minimum inhibitory concentration (MIC) of the compounds.
| Compound | MIC (mg/mL) | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| NS2 | <6.25 | <6.25 | 25 | <6.25 | 50 | <6.25 |
| Zn(NS2)2 | <6.25 | <6.25 | 12.50 | <6.25 | <6.25 | <6.25 |
| Cd(NS2)2 | <6.25 | — | 100 | — | <6.25 | — |
| Ni(NS2)2 | — | 100 | 100 | — | — | — |
| Cu(NS2)2 | — | — | — | — | — | — |
| NS4 | — | — | — | — | — | 12.50 |
| Zn(NS4)2 | — | — | — | — | — | 50 |
| Cd(NS4)2 | — | — | <6.25 | — | — | — |
| Ni(NS4)2 | 25 | — | — | — | — | 50 |
| Cu(NS4)2 | <6.25 | — | — | — | — | <6.25 |
| SBDTC | <6.25 | <6.25 | <6.25 | <6.25 | 0.78* | <6.25 |
| Streptomycin | 0.001563* | 0.000391* | >0.10* | 0.0008* | 0.004* | 0.004* |
| Neomycin | N/A | 1.10* | 0.0039* | 0.0064* | N/A | 0.032* |
| Chloramphenicol | 0.005* | 0.01* | 0.05* | 0.004* | 0.02* | 0.002* |
— refers to the absence of an MIC value for a certain compound as it was not investigated for its MIC due to its low activity. *refers to an MIC value that was obtained from the previous literature or experiments. N/A: (not available).
(a)
| Compound | Gram-positive bacteria | Gram-negative bacteria | Fungus | ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| NS2 | 17.60 | 21.63 | 19.01 | 15.62 | 13.88 | 19.60 | — |
| Zn(NS2)2 | 16.23 | 18.12 | 18.34 | 8.60 | 13.63 | 16.99 | 23.15 |
| Cd(NS2)2 | 8.90 | 8.16 | 25.76 | 7.43 | 15.27 | 8.33 | 29.98 |
| Ni(NS2)2 | 7.40 | 8.51 | 13.53 | — | 8.88 | — | 17.17 |
| Cu(NS2)2 | 7.09 | — | — | — | 7.45 | — | — |
| NS4 | — | 6.53 | — | — | — | 11.50 | — |
| Zn(NS4)2 | 9.19 | 8.17 | 7.40 | — | — | 9.69 | — |
| Cd(NS4)2 | 7.77 | 6.61 | 30.05 | — | — | 6.81 | — |
| Ni(NS4)2 | 10.87 | 10.22 | 9.13 | — | — | 12.99 | — |
| Cu(NS4)2 | 10.33 | 6.64 | 8.21 | — | — | 9.99 | — |
(b)
| Controls and reference compounds | Gram-positive bacteria | Gram-negative bacteria | Fungus | ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| DMSO | — | — | — | — | — | — | — |
| Streptomycin | 14.08 | 15.67 | 12.20 | 14.44 | 13.54 | Not available | |
| Neomycin | 18.14 | 18.52 | 18.57 | 16.58 | 21.87 | 18.91 | |
| Chloramphenicol | 25.86 | 21.70 | 25.87 | — | 15.01 | 19.80 | |
| SBDTC | 19.07 | 22.73 | 13.33 | 15.70 | 14.90 | 21.19 | 18.57 |
| Amphotericin B | 19.17 | ||||||
*Zones of inhibition of diameters 14 mm and above were considered to be significant, 9 mm–14 mm were considered moderate, and less than 9 mm were considered weak and insignificant. (—) refers to absence of measurable inhibitory action.